A three-marker signature identifies senescence in human breast cancer exposed to neoadjuvant chemotherapy

El-Sadoni, M., Shboul, S. A., Alhesa, A., Shahin, N. A., Alsharaiah, E., Ismail, M. A., Ababneh, N. A., Alotaibi, M. R., Azab, B., & Saleh, T. (2023). A three-marker signature identifies senescence in human breast cancer exposed to neoadjuvant chemotherapy. Cancer Chemotherapy and Pharmacology, 91(4), 345–360. https://doi.org/10.1007/s00280-023-04523-w
Authors:
Mohammed El-Sadoni
Sofian Al Shboul
Ahmad Alhesa
Nisreen Abu Shahin
Elham Alsharaiah
Mohammad A Ismail
Nidaa A Ababneh
Moureq R Alotaibi
Bilal Azab
Tareq Saleh
Affiliated Authors:
Bilal Azab
Columbia Affiliation:
Subjects:
Breast Neoplasms (MeSH)
Author Keywords:
breast cancer
ki-67
lamin b1
neoadjuvant chemotherapy
p16<sup>ink4a</sup>
senescence
p16ink4a
elink
Publication Type:
Article
Unique ID:
10.1007/s00280-023-04523-w
PMID:
36964435
DOI:
10.1007/s00280-023-04523-w
Journal:
Cancer Chemotherapy and Pharmacology
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record

Record Created: